In CNS trials, high placebo rates have been blamed for the late-stage failure of promising treatments. Many industry-sponsored CNS trials today include at least one and usually multiple mechanisms to minimize placebo response. This whitepaper:

  • Describes the causes of placebo response
  • Examines frequently used placebo response mitigation strategies
  • Discusses their effectiveness.

 

Click Here to Visit the Full VeraSci Site